glp-1 drug boom Eli Lilly, Novo Nordisk expand operations amid 1 medications or looking to feel their best every day. The next big thing in
Description
Exendin-4 and GLP-1 decreases induced expression of ICAM-1, VCAM-1 and RAGE in human retinal pigment epithelial cells
Tirzepatide (Zepbound, Mounjaro) This is a dual-agonist medication, meaning it targets both GLP-1 and GIP receptors
To view a copy of this licence, visit About this article Cite this article Ibrahim, S.S., Ibrahim, R.S., Arabi, B
The approval status and availability of this class of drugs vary widely across the globe
Download the graphics below to share about this topic
